A 0 1 0 1 O
PN 2 4 2 4 O
is 5 7 5 7 O
defined 8 15 8 15 O
as 16 18 16 18 O
a 19 20 19 20 O
neurofibroma 21 33 21 33 B-chronic_disease
that 34 38 34 38 O
has 39 42 39 42 O
grown 43 48 43 48 O
along 49 54 49 54 O
the 55 58 55 58 O
length 59 65 59 65 O
of 66 68 66 68 O
a 69 70 69 70 O
nerve 71 76 71 76 O
and 77 80 77 80 O
may 81 84 81 84 O
involve 85 92 85 92 O
multiple 93 101 93 101 O
fascicles 102 111 102 111 O
and 112 115 112 115 O
branches 116 124 116 124 O

A 0 1 125 126 O
distinctive 2 13 127 138 O
bony 14 18 139 143 O
lesion 19 25 144 150 O
( 26 27 151 152 O
dysplasia 27 36 152 161 B-chronic_disease
of 37 39 162 164 I-chronic_disease
the 40 43 165 168 I-chronic_disease
sphenoid 44 52 169 177 I-chronic_disease
bone 53 57 178 182 I-chronic_disease
or 58 60 183 185 O
dysplasia 61 70 186 195 O
or 71 73 196 198 O
thinning 74 82 199 207 O
of 83 85 208 210 O
long 86 90 211 215 O
bone 91 95 216 220 O
cortex 96 102 221 227 O
) 102 103 227 228 O

A 0 1 229 230 O
first 2 7 231 236 O
- 7 8 236 237 O
degree 8 14 237 243 O
relative 15 23 244 252 O
with 24 28 253 257 O
NF1 29 32 258 261 B-chronic_disease

A 0 1 262 263 O
spinal 2 8 264 270 O
PN 9 11 271 273 O
involves 12 20 274 282 O
two 21 24 283 286 B-lower_bound
or 25 27 287 289 O
more 28 32 290 294 O
levels 33 39 295 301 O
with 40 44 302 306 O
connection 45 55 307 317 O
between 56 63 318 325 O
the 64 67 326 329 O
levels 68 74 330 336 O
or 75 77 337 339 O
extending 78 87 340 349 O
laterally 88 97 350 359 O
along 98 103 360 365 O
the 104 107 366 369 O
nerve 108 113 370 375 O

AST 0 3 376 379 B-clinical_variable
and 4 7 380 383 O
ALT 8 11 384 387 B-clinical_variable
less 12 16 388 392 O
than 17 21 393 397 O
or 22 24 398 400 O
equal 25 30 401 406 O
to 31 33 407 409 O
upper 34 39 410 415 O
limit 40 45 416 421 O
of 46 48 422 424 O
normal 49 55 425 431 O
( 56 57 432 433 O
ULN 57 60 433 436 O
) 60 61 436 437 O

Absolute 0 8 438 446 B-clinical_variable
neutrophil 9 19 447 457 I-clinical_variable
count 20 25 458 463 I-clinical_variable
> 26 27 464 465 O
= 27 28 465 466 O
1.5 29 32 467 470 B-lower_bound
( 33 34 471 472 I-lower_bound
SqrRoot 34 41 472 479 I-lower_bound
) 41 42 479 480 I-lower_bound
10 43 45 481 483 I-lower_bound
^ 45 46 483 484 I-lower_bound
9 46 47 484 485 I-lower_bound
/ 47 48 485 486 I-lower_bound
L 48 49 486 487 I-lower_bound

Active 0 6 488 494 B-chronic_disease
untreated 7 16 495 504 I-chronic_disease
infection 17 26 505 514 I-chronic_disease

Age 0 3 515 518 B-age
( 4 5 519 520 O
must 5 9 520 524 O
have 10 14 525 529 O
BSA 15 18 530 533 B-clinical_variable
greater 19 26 534 541 O
than 27 31 542 546 O
or 32 34 547 549 O
equal 35 40 550 555 O
to 41 43 556 558 O
0.55 44 48 559 563 B-lower_bound
m2 49 51 564 566 I-lower_bound
) 51 52 566 567 O

At 0 2 568 570 O
least 3 8 571 576 O
150 9 12 577 580 B-lower_bound
days 13 17 581 585 I-lower_bound
must 18 22 586 590 O
have 23 27 591 595 O
elapsed 28 35 596 603 O
if 36 38 604 606 O
prior 39 44 607 612 O
TBI 45 48 613 616 B-chronic_disease
or 49 51 617 619 O
if 52 54 620 622 O
greater 55 62 623 630 O
than 63 67 631 635 O
or 68 70 636 638 O
equal 71 76 639 644 O
to 77 79 645 647 O
50 80 82 648 650 B-lower_bound
% 82 83 650 651 I-lower_bound
radiation 84 93 652 661 B-treatment
of 94 96 662 664 I-treatment
pelvis 97 103 665 671 I-treatment

At 0 2 672 674 O
least 3 8 675 680 O
42 9 11 681 683 B-lower_bound
days 12 16 684 688 I-lower_bound
must 17 21 689 693 O
have 22 26 694 698 O
elapsed 27 34 699 706 O
if 35 37 707 709 O
other 38 43 710 715 O
substantial 44 55 716 727 B-treatment
BM 56 58 728 730 I-treatment
radiation 59 68 731 740 I-treatment

Biologic 0 8 741 749 B-treatment
( 9 10 750 751 O
anti 10 14 751 755 B-treatment
- 14 15 755 756 I-treatment
neoplastic 15 25 756 766 I-treatment
agent 26 31 767 772 I-treatment
): 31 33 772 774 O
At 34 36 775 777 O
least 37 42 778 783 O
7 43 44 784 785 B-lower_bound
days 45 49 786 790 I-lower_bound
after 50 55 791 796 I-lower_bound
the 56 59 797 800 O
last 60 64 801 805 O
dose 65 69 806 810 O
of 70 72 811 813 O
a 73 74 814 815 O
biologic 75 83 816 824 B-treatment
agent 84 89 825 830 I-treatment

Contraception 0 13 831 844 O
: 13 14 844 845 O
Women 15 20 846 851 B-gender
of 21 23 852 854 O
child 24 29 855 860 O
- 29 30 860 861 O
bearing 30 37 861 868 O
potential 38 47 869 878 O
must 48 52 879 883 O
agree 53 58 884 889 B-contraception_consent
to 59 61 890 892 I-contraception_consent
use 62 65 893 896 I-contraception_consent
an 66 68 897 899 I-contraception_consent
effective 69 78 900 909 I-contraception_consent
method 79 85 910 916 I-contraception_consent
of 86 88 917 919 I-contraception_consent
birth 89 94 920 925 I-contraception_consent
control 95 102 926 933 I-contraception_consent
during 103 109 934 940 O
treatment 110 119 941 950 B-treatment
and 120 123 951 954 O
for 124 127 955 958 O
3 128 129 959 960 B-upper_bound
months 130 136 961 967 I-upper_bound
after 137 142 968 973 I-upper_bound
receiving 143 152 974 983 O
their 153 158 984 989 O
last 159 163 990 994 O
dose 164 168 995 999 O
of 169 171 1000 1002 O
study 172 177 1003 1008 B-treatment
drug 178 182 1009 1013 I-treatment

Disease 0 7 1014 1021 O
status 8 14 1022 1028 O
: 14 15 1028 1029 O
Phase 16 21 1030 1035 O
I 22 23 1036 1037 O
: 23 24 1037 1038 O
Patients 25 33 1039 1047 O
with 34 38 1048 1052 O
refractory 39 49 1053 1063 O
solid 50 55 1064 1069 B-cancer
tumors 56 62 1070 1076 I-cancer
including 63 72 1077 1086 O
patients 73 81 1087 1095 O
with 82 86 1096 1100 O
NF1 87 90 1101 1104 B-cancer
and 91 94 1105 1108 O
MPNST 95 100 1109 1114 B-cancer
must 101 105 1115 1119 O
have 106 110 1120 1124 O
evaluable 111 120 1125 1134 O
disease 121 128 1135 1142 O
, 128 129 1142 1143 O
patients 130 138 1144 1152 O
with 139 143 1153 1157 O
refractory 144 154 1158 1168 O
leukemia 155 163 1169 1177 B-cancer
must 164 168 1178 1182 O
have 169 173 1183 1187 O
M2 174 176 1188 1190 O
or 177 179 1191 1193 O
M3 180 182 1194 1196 O
bone 183 187 1197 1201 O
marrow 188 194 1202 1208 O

Drugs 0 5 1209 1214 O
that 6 10 1215 1219 O
strongly 11 19 1220 1228 B-treatment
inhibit 20 27 1229 1236 I-treatment
or 28 30 1237 1239 I-treatment
potentiate 31 41 1240 1250 I-treatment
CYP3A4 42 48 1251 1257 I-treatment

During 0 6 1258 1264 O
Phase 7 12 1265 1270 O
I 13 14 1271 1272 O
: 14 15 1272 1273 O
patients 16 24 1274 1282 O
who 25 28 1283 1286 O
have 29 33 1287 1291 O
received 34 42 1292 1300 O
these 43 48 1301 1306 O
drugs 49 54 1307 1312 O
within 55 61 1313 1319 O
14 62 64 1320 1322 B-upper_bound
days 65 69 1323 1327 I-upper_bound
or 70 72 1328 1330 O
within 73 79 1331 1337 O
5 80 81 1338 1339 B-upper_bound
half 82 86 1340 1344 I-upper_bound
- 86 87 1344 1345 I-upper_bound
lives 87 92 1345 1350 I-upper_bound
of 93 95 1351 1353 O
the 96 99 1354 1357 O
drug 100 104 1358 1362 O
( 105 106 1363 1364 O
whichever 106 115 1364 1373 O
is 116 118 1374 1376 O
longer 119 125 1377 1383 O
) 125 126 1383 1384 O
prior 127 132 1385 1390 O
to 133 135 1391 1393 O
study 136 141 1394 1399 O
initiation 142 152 1400 1410 O
will 153 157 1411 1415 O
be 158 160 1416 1418 O
excluded 161 169 1419 1427 O

Enrollment 0 10 1428 1438 O
in 11 13 1439 1441 O
the 14 17 1442 1445 O
cohort 18 24 1446 1452 O
of 25 27 1453 1455 O
patients 28 36 1456 1464 O
with 37 41 1465 1469 O
NF1 42 45 1470 1473 B-chronic_disease
inoperable 46 56 1474 1484 O
plexiform 57 66 1485 1494 B-cancer
neurofibromas 67 80 1495 1508 I-cancer
( 81 82 1509 1510 I-cancer
PN 82 84 1510 1512 I-cancer
) 84 85 1512 1513 I-cancer
is 86 88 1514 1516 O
temporarily 89 100 1517 1528 O
suspended 101 110 1529 1538 O
as 111 113 1539 1541 O
of 114 116 1542 1544 O
Amendment 117 126 1545 1554 O
G 127 128 1555 1556 O
as 129 131 1557 1559 O
requested 132 141 1560 1569 O
by 142 144 1570 1572 O
the 145 148 1573 1576 O
FDA 149 152 1577 1580 O
due 153 156 1581 1584 O
to 157 159 1585 1587 O
IND 160 163 1588 1591 O
Safety 164 170 1592 1598 O
Report 171 177 1599 1605 O
of 178 180 1606 1608 O
07 181 183 1609 1611 O
October 184 191 1612 1619 O
2016 192 196 1620 1624 O

Fertile 0 7 1625 1632 O
men 8 11 1633 1636 B-gender
must 12 16 1637 1641 O
also 17 21 1642 1646 O
agree 22 27 1647 1652 B-contraception_consent
to 28 30 1653 1655 I-contraception_consent
use 31 34 1656 1659 I-contraception_consent
an 35 37 1660 1662 I-contraception_consent
acceptable 38 48 1663 1673 I-contraception_consent
method 49 55 1674 1680 I-contraception_consent
of 56 58 1681 1683 I-contraception_consent
birth 59 64 1684 1689 I-contraception_consent
control 65 72 1690 1697 I-contraception_consent
while 73 78 1698 1703 O
on 79 81 1704 1706 O
study 82 87 1707 1712 O
drug 88 92 1713 1717 O
and 93 96 1718 1721 O
for 97 100 1722 1725 O
at 101 103 1726 1728 O
least 104 109 1729 1734 O
3 110 111 1735 1736 B-lower_bound
months 112 118 1737 1743 I-lower_bound
after 119 124 1744 1749 I-lower_bound
last 125 129 1750 1754 O
dose 130 134 1755 1759 O

For 0 3 1760 1763 O
DIPG 4 8 1764 1768 B-cancer
typical 9 16 1769 1776 O
MRI 17 20 1777 1780 B-treatment
findings 21 29 1781 1789 O
must 30 34 1790 1794 O
be 35 37 1795 1797 O
present 38 45 1798 1805 O
which 46 51 1806 1811 O
include 52 59 1812 1819 O
hypo- 60 65 1820 1825 O
or 66 68 1826 1828 O
isointense 69 79 1829 1839 O
on 80 82 1840 1842 O
T1 83 85 1843 1845 B-treatment
- 85 86 1845 1846 I-treatment
weighted 86 94 1846 1854 I-treatment
imaging 95 102 1855 1862 I-treatment
, 102 103 1862 1863 O
hyperintense 104 116 1864 1876 O
on 117 119 1877 1879 O
FLAIR 120 125 1880 1885 B-treatment
or 126 128 1886 1888 O
T2 129 131 1889 1891 B-treatment
- 131 132 1891 1892 I-treatment
weighted 132 140 1892 1900 I-treatment
imaging 141 148 1901 1908 I-treatment
, 148 149 1908 1909 O
epicenter 150 159 1910 1919 O
in 160 162 1920 1922 O
the 163 166 1923 1926 O
pons 167 171 1927 1931 O
in 172 174 1932 1934 O
the 175 178 1935 1938 O
face 179 183 1939 1943 O
of 184 186 1944 1946 O
a 187 188 1947 1948 O
typical 189 196 1949 1956 O
clinical 197 205 1957 1965 O
presentation 206 218 1966 1978 O

For 0 3 1979 1982 O
NF1 4 7 1983 1986 B-cancer
PN 8 10 1987 1989 O
there 11 16 1990 1995 O
is 17 19 1996 1998 O
no 20 22 1999 2001 O
standard 23 31 2002 2010 B-treatment
medical 32 39 2011 2018 I-treatment
therapy 40 47 2019 2026 I-treatment
, 47 48 2026 2027 O
and 49 52 2028 2031 O
therefore 53 62 2032 2041 O
no 63 65 2042 2044 O
requirement 66 77 2045 2056 O
for 78 81 2057 2060 O
prior 82 87 2061 2066 B-treatment
therapy 88 95 2067 2074 I-treatment

For 0 3 2075 2078 O
agents 4 10 2079 2085 O
that 11 15 2086 2090 O
have 16 20 2091 2095 O
known 21 26 2096 2101 O
adverse 27 34 2102 2109 O
events 35 41 2110 2116 O
occurring 42 51 2117 2126 O
beyond 52 58 2127 2133 O
7 59 60 2134 2135 B-lower_bound
days 61 65 2136 2140 I-lower_bound
after 66 71 2141 2146 I-lower_bound
administration 72 86 2147 2161 O
, 86 87 2161 2162 O
this 88 92 2163 2167 O
period 93 99 2168 2174 O
must 100 104 2175 2179 O
be 105 107 2180 2182 O
extended 108 116 2183 2191 O
beyond 117 123 2192 2198 O
the 124 127 2199 2202 O
time 128 132 2203 2207 O
during 133 139 2208 2214 O
which 140 145 2215 2220 O
adverse 146 153 2221 2228 O
events 154 160 2229 2235 O
are 161 164 2236 2239 O
known 165 170 2240 2245 O
to 171 173 2246 2248 O
occur 174 179 2249 2254 O

HSCT 0 4 2255 2259 B-treatment
: 4 5 2259 2260 O
greater 6 13 2261 2268 O
than 14 18 2269 2273 O
or 19 21 2274 2276 O
equal 22 27 2277 2282 O
to 28 30 2283 2285 O
56 31 33 2286 2288 B-lower_bound
days 34 38 2289 2293 I-lower_bound
from 39 43 2294 2298 O
stem 44 48 2299 2303 B-treatment
cell 49 53 2304 2308 I-treatment
transplant 54 64 2309 2319 I-treatment
with 65 69 2320 2324 O
no 70 72 2325 2327 O
evidence 73 81 2328 2336 O
of 82 84 2337 2339 O
active 85 91 2340 2346 O
graft 92 97 2347 2352 B-chronic_disease
vs. 98 101 2353 2356 I-chronic_disease
host 102 106 2357 2361 I-chronic_disease
disease 107 114 2362 2369 I-chronic_disease

Hemoglobin 0 10 2370 2380 B-clinical_variable
> 11 12 2381 2382 O
10 13 15 2383 2385 B-lower_bound
g 16 17 2386 2387 I-lower_bound
/ 17 18 2387 2388 I-lower_bound
dL 18 20 2388 2390 I-lower_bound

Histologic 0 10 2391 2401 O
confirmation 11 23 2402 2414 O
of 24 26 2415 2417 O
PN 27 29 2418 2420 B-cancer
tumor 30 35 2421 2426 I-cancer
is 36 38 2427 2429 O
not 39 42 2430 2433 O
necessary 43 52 2434 2443 O
in 53 55 2444 2446 O
the 56 59 2447 2450 O
presence 60 68 2451 2459 O
of 69 71 2460 2462 O
consistent 72 82 2463 2473 O
clinical 83 91 2474 2482 O
and 92 95 2483 2486 O
radiographic 96 108 2487 2499 O
findings 109 117 2500 2508 O
, 117 118 2508 2509 O
but 119 122 2510 2513 O
should 123 129 2514 2520 O
be 130 132 2521 2523 O
considered 133 143 2524 2534 O
if 144 146 2535 2537 O
malignant 147 156 2538 2547 O
degeneration 157 169 2548 2560 O
of 170 172 2561 2563 O
a 173 174 2564 2565 O
PN 175 177 2566 2568 O
is 178 180 2569 2571 O
clinically 181 191 2572 2582 O
suspected 192 201 2583 2592 O

History 0 7 2593 2600 O
of 8 10 2601 2603 O
allergic 11 19 2604 2612 O
reactions 20 29 2613 2622 O
attributed 30 40 2623 2633 O
to 41 43 2634 2636 O
compounds 44 53 2637 2646 B-allergy_name
of 54 56 2647 2649 I-allergy_name
similar 57 64 2650 2657 I-allergy_name
chemical 65 73 2658 2666 I-allergy_name
or 74 76 2667 2669 I-allergy_name
biologic 77 85 2670 2678 I-allergy_name
composition 86 97 2679 2690 I-allergy_name
to 98 100 2691 2693 I-allergy_name
PLX3397 101 108 2694 2701 I-allergy_name
or 109 111 2702 2704 O
other 112 117 2705 2710 B-allergy_name
agents 118 124 2711 2717 I-allergy_name
used 125 129 2718 2722 I-allergy_name
in 130 132 2723 2725 O
study 133 138 2726 2731 O

Immunotherapy 0 13 2732 2745 B-treatment
: 13 14 2745 2746 O
At 15 17 2747 2749 O
least 18 23 2750 2755 O
42 24 26 2756 2758 B-lower_bound
days 27 31 2759 2763 I-lower_bound
after 32 37 2764 2769 I-lower_bound
the 38 41 2770 2773 O
completion 42 52 2774 2784 O
of 53 55 2785 2787 O
any 56 59 2788 2791 O
type 60 64 2792 2796 O
of 65 67 2797 2799 O
immunotherapy 68 81 2800 2813 B-treatment
, 81 82 2813 2814 O
e.g. 83 87 2815 2819 O
tumor 88 93 2820 2825 B-treatment
vaccines 94 102 2826 2834 I-treatment

Individuals 0 11 2835 2846 O
who 12 15 2847 2850 O
are 16 19 2851 2854 B-pregnancy
pregnant 20 28 2855 2863 I-pregnancy
or 29 31 2864 2866 O
breast 32 38 2867 2873 O
feeding 39 46 2874 2881 O
or 47 49 2882 2884 O
who 50 53 2885 2888 O
become 54 60 2889 2895 B-pregnancy
pregnant 61 69 2896 2904 I-pregnancy
while 70 75 2905 2910 O
enrolled 76 84 2911 2919 O
on 85 87 2920 2922 O
this 88 92 2923 2927 O
trial 93 98 2928 2933 O
will 99 103 2934 2938 O
be 104 106 2939 2941 O
excluded 107 115 2942 2950 O
from 116 120 2951 2955 O
participation 121 134 2956 2969 O
, 134 135 2969 2970 O
due 136 139 2971 2974 O
to 140 142 2975 2977 O
the 143 146 2978 2981 O
unknown 147 154 2982 2989 O
effects 155 162 2990 2997 O
of 163 165 2998 3000 O
PLX3397 166 173 3001 3008 B-treatment
on 174 176 3009 3011 O
a 177 178 3012 3013 O
growing 179 186 3014 3021 O
fetus 187 192 3022 3027 O
or 193 195 3028 3030 O
newborn 196 203 3031 3038 O
child 204 209 3039 3044 O

Individuals 0 11 3045 3056 O
who 12 15 3057 3060 O
require 16 23 3061 3068 O
therapy 24 31 3069 3076 B-treatment
with 32 36 3077 3081 O
warfarin 37 45 3082 3090 B-treatment

Individuals 0 11 3091 3102 O
with 12 16 3103 3107 O
malignant 17 26 3108 3117 B-cancer
peripheral 27 37 3118 3128 I-cancer
nerve 38 43 3129 3134 I-cancer
sheath 44 50 3135 3141 I-cancer
tumors 51 57 3142 3148 I-cancer
will 58 62 3149 3153 O
not 63 66 3154 3157 O
be 67 69 3158 3160 O
eligible 70 78 3161 3169 O
to 79 81 3170 3172 O
participate 82 93 3173 3184 O
in 94 96 3185 3187 O
the 97 100 3188 3191 O
phase 101 106 3192 3197 O
II 107 109 3198 3200 O
portion 110 117 3201 3208 O
of 118 120 3209 3211 O
the 121 124 3212 3215 O
trial 125 130 3216 3221 O

Known 0 5 3222 3227 O
active 6 12 3228 3234 O
or 13 15 3235 3237 O
chronic 16 23 3238 3245 O
human 24 29 3246 3251 B-chronic_disease
immunodeficiency 30 46 3252 3268 I-chronic_disease
virus 47 52 3269 3274 I-chronic_disease
( 53 54 3275 3276 I-chronic_disease
HIV 54 57 3276 3279 I-chronic_disease
) 57 58 3279 3280 I-chronic_disease
or 59 61 3281 3283 O
hepatitis 62 71 3284 3293 B-chronic_disease
C 72 73 3294 3295 I-chronic_disease
virus 74 79 3296 3301 I-chronic_disease
( 80 81 3302 3303 I-chronic_disease
HCV 81 84 3303 3306 I-chronic_disease
) 84 85 3306 3307 I-chronic_disease
infection 86 95 3308 3317 I-chronic_disease
, 95 96 3317 3318 O
or 97 99 3319 3321 O
positive 100 108 3322 3330 O
hepatitis 109 118 3331 3340 B-chronic_disease
B 119 120 3341 3342 I-chronic_disease
( 121 122 3343 3344 I-chronic_disease
Hep 122 125 3344 3347 I-chronic_disease
B 126 127 3348 3349 I-chronic_disease
) 127 128 3349 3350 I-chronic_disease
surface 129 136 3351 3358 O
antigen 137 144 3359 3366 O

Known 0 5 3367 3372 O
chronic 6 13 3373 3380 O
Hepatitis 14 23 3381 3390 B-chronic_disease
B 24 25 3391 3392 I-chronic_disease
or 26 28 3393 3395 I-chronic_disease
C 29 30 3396 3397 I-chronic_disease
, 30 31 3397 3398 O
or 32 34 3399 3401 O
HIV 35 38 3402 3405 B-chronic_disease
infection 39 48 3406 3415 I-chronic_disease

Lansky 0 6 3416 3422 B-clinical_variable
greater 7 14 3423 3430 O
than 15 19 3431 3435 O
or 20 22 3436 3438 O
equal 23 28 3439 3444 O
to 29 31 3445 3447 O
50 32 34 3448 3450 B-lower_bound
% 34 35 3450 3451 I-lower_bound
for 36 39 3452 3455 O
patients 40 48 3456 3464 O
less 49 53 3465 3469 O
than 54 58 3470 3474 O
or 59 61 3475 3477 O
eqal 62 66 3478 3482 O
to 67 69 3483 3485 O
16 70 72 3486 3488 B-upper_bound
years 73 78 3489 3494 I-upper_bound
of 79 81 3495 3497 O
age 82 85 3498 3501 B-age

Monoclonal 0 10 3502 3512 B-treatment
antibodies 11 21 3513 3523 I-treatment
: 21 22 3523 3524 O
At 23 25 3525 3527 O
least 26 31 3528 3533 O
3 32 33 3534 3535 B-lower_bound
half 34 38 3536 3540 I-lower_bound
- 38 39 3540 3541 I-lower_bound
lives 39 44 3541 3546 I-lower_bound
of 45 47 3547 3549 O
the 48 51 3550 3553 O
antibody 52 60 3554 3562 O
after 61 66 3563 3568 O
the 67 70 3569 3572 O
last 71 75 3573 3577 O
dose 76 80 3578 3582 O
of 81 83 3583 3585 O
a 84 85 3586 3587 O
monoclonal 86 96 3588 3598 B-treatment
antibody 97 105 3599 3607 I-treatment

Myelosuppressive 0 16 3608 3624 B-treatment
chemotherapy 17 29 3625 3637 I-treatment
: 29 30 3637 3638 O
At 31 33 3639 3641 O
least 34 39 3642 3647 O
21 40 42 3648 3650 B-lower_bound
days 43 47 3651 3655 I-lower_bound
after 48 53 3656 3661 I-lower_bound
the 54 57 3662 3665 O
last 58 62 3666 3670 O
dose 63 67 3671 3675 O
of 68 70 3676 3678 O
myelosuppressive 71 87 3679 3695 B-treatment
chemotherapy 88 100 3696 3708 I-treatment
( 101 102 3709 3710 O
42 102 104 3710 3712 O
days 105 109 3713 3717 O
if 110 112 3718 3720 O
prior 113 118 3721 3726 O
nitrosourea 119 130 3727 3738 B-treatment
) 130 131 3738 3739 O

Ongoing 0 7 3740 3747 O
treatment 8 17 3748 3757 B-treatment
with 18 22 3758 3762 O
any 23 26 3763 3766 O
other 27 32 3767 3772 O
cancer 33 39 3773 3779 B-treatment
therapy 40 47 3780 3787 I-treatment
or 48 50 3788 3790 O
investigational 51 66 3791 3806 B-treatment
agent 67 72 3807 3812 I-treatment
, 72 73 3812 3813 O
with 74 78 3814 3818 O
the 79 82 3819 3822 O
exception 83 92 3823 3832 O
of 93 95 3833 3835 O
IT 96 98 3836 3838 O
chemotherapy 99 111 3839 3851 B-treatment
for 112 115 3852 3855 O
leukemia 116 124 3856 3864 B-cancer
, 124 125 3864 3865 O
when 126 130 3866 3870 O
indicated 131 140 3871 3880 O

Optic 0 5 3881 3886 B-cancer
glioma 6 12 3887 3893 I-cancer

Optic 0 5 3894 3899 B-cancer
pathway 6 13 3900 3907 I-cancer
glioma 14 20 3908 3914 I-cancer
are 21 24 3915 3918 O
located 25 32 3919 3926 O
in 33 35 3927 3929 O
the 36 39 3930 3933 O
optic 40 45 3934 3939 O
pathway 46 53 3940 3947 O
and 54 57 3948 3951 O
are 58 61 3952 3955 O
typically 62 71 3956 3965 O
hypo- 72 77 3966 3971 O
or 78 80 3972 3974 O
iso 81 84 3975 3978 O
- 84 85 3978 3979 O
intense 85 92 3979 3986 O
on 93 95 3987 3989 O
T1 96 98 3990 3992 O
and 99 102 3993 3996 O
hyperintense 103 115 3997 4009 O
on 116 118 4010 4012 O
T2 119 121 4013 4015 O
- 121 122 4015 4016 O
weighted 122 130 4016 4024 O
images 131 137 4025 4031 O

Others 0 6 4032 4038 O
: 6 7 4038 4039 O
greater 8 15 4040 4047 O
than 16 20 4048 4052 O
or 21 23 4053 4055 O
equal 24 29 4056 4061 O
to 30 32 4062 4064 O
7 33 34 4065 4066 B-lower_bound
days 35 39 4067 4071 I-lower_bound
from 40 44 4072 4076 O
last 45 49 4077 4081 O
dose 50 54 4082 4086 O
of 55 57 4087 4089 O
short 58 63 4090 4095 B-treatment
active 64 70 4096 4102 I-treatment
hematopoietic 71 84 4103 4116 I-treatment
growth 85 91 4117 4123 I-treatment
factors 92 99 4124 4131 I-treatment
, 99 100 4131 4132 O
i.e. 101 105 4133 4137 O
filgrastim 106 116 4138 4148 B-treatment
, 116 117 4148 4149 O
greater 118 125 4150 4157 O
than 126 130 4158 4162 O
or 131 133 4163 4165 O
equal 134 139 4166 4171 O
to 140 142 4172 4174 O
14 143 145 4175 4177 B-lower_bound
days 146 150 4178 4182 I-lower_bound
for 151 154 4183 4186 O
long 155 159 4187 4191 O
- 159 160 4191 4192 O
acting 160 166 4192 4198 O
, 166 167 4198 4199 O
i.e. 168 172 4200 4204 O
pegfilgrastim 173 186 4205 4218 B-treatment

Patient 0 7 4219 4226 O
accrual 8 15 4227 4234 O
of 16 18 4235 4237 O
patients 19 27 4238 4246 O
with 28 32 4247 4251 O
NF1 33 36 4252 4255 B-cancer
and 37 40 4256 4259 O
MPNST 41 46 4260 4265 B-cancer
may 47 50 4266 4269 O
continue 51 59 4270 4278 O
in 60 62 4279 4281 O
the 63 66 4282 4285 O
Phase 67 72 4286 4291 O
I 73 74 4292 4293 O
Portion 75 82 4294 4301 O

Patients 0 8 4302 4310 O
must 9 13 4311 4315 O
have 14 18 4316 4320 O
fully 19 24 4321 4326 O
recovered 25 34 4327 4336 O
( 35 36 4337 4338 O
to 36 38 4338 4340 O
Grade 39 44 4341 4346 O
1 45 46 4347 4348 O
) 46 47 4348 4349 O
from 48 52 4350 4354 O
the 53 56 4355 4358 O
acute 57 62 4359 4364 O
toxic 63 68 4365 4370 O
effects 69 76 4371 4378 O
of 77 79 4379 4381 O
all 80 83 4382 4385 O
prior 84 89 4386 4391 B-treatment
anti 90 94 4392 4396 I-treatment
- 94 95 4396 4397 I-treatment
cancer 95 101 4397 4403 I-treatment
therapy 102 109 4404 4411 I-treatment

Patients 0 8 4412 4420 O
must 9 13 4421 4425 O
have 14 18 4426 4430 O
relapsed 19 27 4431 4439 O
after 28 33 4440 4445 O
or 34 36 4446 4448 O
be 37 39 4449 4451 O
refractory 40 50 4452 4462 O
to 51 53 4463 4465 O
effective 54 63 4466 4475 O
standard 64 72 4476 4484 B-treatment
therapies 73 82 4485 4494 I-treatment

Patients 0 8 4495 4503 O
with 9 13 4504 4508 O
diffuse 14 21 4509 4516 B-cancer
intrinsic 22 31 4517 4526 I-cancer
pontine 32 39 4527 4534 I-cancer
glioma 40 46 4535 4541 I-cancer
( 47 48 4542 4543 I-cancer
DIPG 48 52 4543 4547 I-cancer
) 52 53 4547 4548 O
or 54 56 4549 4551 O
optic 57 62 4552 4557 B-cancer
pathway 63 70 4558 4565 I-cancer
glioma 71 77 4566 4572 I-cancer
are 78 81 4573 4576 O
exempt 82 88 4577 4583 O
from 89 93 4584 4588 O
histologic 94 104 4589 4599 O
verification 105 117 4600 4612 O

Patients 0 8 4613 4621 O
with 9 13 4622 4626 O
leukemia 14 22 4627 4635 B-cancer
receiving 23 32 4636 4645 O
corticosteroids 33 48 4646 4661 B-treatment
or 49 51 4662 4664 O
hydroxyurea 52 63 4665 4676 B-treatment
are 64 67 4677 4680 O
eligible 68 76 4681 4689 O
provided 77 85 4690 4698 O
that 86 90 4699 4703 O
the 91 94 4704 4707 O
corticosteroids 95 110 4708 4723 O
are 111 114 4724 4727 O
not 115 118 4728 4731 O
being 119 124 4732 4737 O
used 125 129 4738 4742 O
to 130 132 4743 4745 O
manage 133 139 4746 4752 O
GVHD 140 144 4753 4757 B-chronic_disease
and 145 148 4758 4761 O
there 149 154 4762 4767 O
has 155 158 4768 4771 O
been 159 163 4772 4776 O
no 164 166 4777 4779 O
increase 167 175 4780 4788 O
in 176 178 4789 4791 O
corticosteroid 179 193 4792 4806 O
of 194 196 4807 4809 O
hydroxyurea 197 208 4810 4821 O
dose 209 213 4822 4826 O
for 214 217 4827 4830 O
7 218 219 4831 4832 B-upper_bound
days 220 224 4833 4837 I-upper_bound
prior 225 230 4838 4843 I-upper_bound
to 231 233 4844 4846 O
starting 234 242 4847 4855 O
PLX3397 243 250 4856 4863 B-treatment

Performance 0 11 4864 4875 O
Status 12 18 4876 4882 O
: 18 19 4882 4883 O
Karnofsky 20 29 4884 4893 B-clinical_variable
greater 30 37 4894 4901 O
than 38 42 4902 4906 O
or 43 45 4907 4909 O
equal 46 51 4910 4915 O
to 52 54 4916 4918 O
50 55 57 4919 4921 B-lower_bound
% 57 58 4921 4922 I-lower_bound
for 59 62 4923 4926 O
patients 63 71 4927 4935 O
> 72 73 4936 4937 O
16 74 76 4938 4940 B-lower_bound
years 77 82 4941 4946 I-lower_bound
of 83 85 4947 4949 O
age 86 89 4950 4953 B-age

Phase 0 5 4954 4959 O
I 6 7 4960 4961 O
: 7 8 4961 4962 O
Patients 9 17 4963 4971 O
must 18 22 4972 4976 O
have 23 27 4977 4981 O
recurrent 28 37 4982 4991 O
or 38 40 4992 4994 O
refractory 41 51 4995 5005 O
solid 52 57 5006 5011 B-cancer
tumors 58 64 5012 5018 I-cancer
or 65 67 5019 5021 O
acute 68 73 5022 5027 B-cancer
leukemia 74 82 5028 5036 I-cancer
( 83 84 5037 5038 O
limited 84 91 5038 5045 O
to 92 94 5046 5048 O
AML 95 98 5049 5052 B-cancer
or 99 101 5053 5055 O
ALL 102 105 5056 5059 B-cancer
) 105 106 5059 5060 O
or 107 109 5061 5063 O
have 110 114 5064 5068 O
been 115 119 5069 5073 O
intolerant 120 130 5074 5084 O
of 131 133 5085 5087 O
prior 134 139 5088 5093 B-treatment
therapies 140 149 5094 5103 I-treatment
, 149 150 5103 5104 O
confirmed 151 160 5105 5114 O
by 161 163 5115 5117 O
the 164 167 5118 5121 O
Laboratory 168 178 5122 5132 O
of 179 181 5133 5135 O
Pathology 182 191 5136 5145 O
, 191 192 5145 5146 O
NCI 193 196 5147 5150 O
, 196 197 5150 5151 O
e.g. 198 202 5152 5156 O
, 202 203 5156 5157 O
solid 204 209 5158 5163 O
tumors 210 216 5164 5170 O
including 217 226 5171 5180 O
rhabdomyosarcoma 227 243 5181 5197 B-cancer
, 243 244 5197 5198 O
Ewing 245 250 5199 5204 B-cancer
sarcoma 251 258 5205 5212 I-cancer
, 258 259 5212 5213 O
soft 260 264 5214 5218 B-cancer
tissue 265 271 5219 5225 I-cancer
sarcomas 272 280 5226 5234 I-cancer

Phase 0 5 5235 5240 O
I 6 7 5241 5242 O
: 7 8 5242 5243 O
greater 9 16 5244 5251 O
than 17 21 5252 5256 O
or 22 24 5257 5259 O
equal 25 30 5260 5265 O
to 31 33 5266 5268 O
3 34 35 5269 5270 B-lower_bound
and 36 39 5271 5274 O
less 40 44 5275 5279 O
than 45 49 5280 5284 O
or 50 52 5285 5287 O
equal 53 58 5288 5293 O
to 59 61 5294 5296 O
21 62 64 5297 5299 B-upper_bound
years 65 70 5300 5305 I-upper_bound
of 71 73 5306 5308 O
age 74 77 5309 5312 B-age

Phase 0 5 5313 5318 O
II 6 8 5319 5321 O
: 8 9 5321 5322 O
greater 10 17 5323 5330 O
than 18 22 5331 5335 O
or 23 25 5336 5338 O
equal 26 31 5339 5344 O
to 32 34 5345 5347 O
3 35 36 5348 5349 B-lower_bound
and 37 40 5350 5353 O
less 41 45 5354 5358 O
than 46 50 5359 5363 O
or 51 53 5364 5366 O
equal 54 59 5367 5372 O
to 60 62 5373 5375 O
35 63 65 5376 5378 B-upper_bound
years 66 71 5379 5384 I-upper_bound
of 72 74 5385 5387 O
age 75 78 5388 5391 B-age

Phase 0 5 5392 5397 O
II 6 8 5398 5400 O
: 8 9 5400 5401 O
inoperable 10 20 5402 5412 O
PN 21 23 5413 5415 B-chronic_disease
causing 24 31 5416 5423 O
morbidity 32 41 5424 5433 O
, 41 42 5433 5434 O
such 43 47 5435 5439 O
as 48 50 5440 5442 O
( 51 52 5443 5444 O
but 52 55 5444 5447 O
not 56 59 5448 5451 O
limited 60 67 5452 5459 O
to 68 70 5460 5462 O
) 70 71 5462 5463 O
head 72 76 5464 5468 B-cancer
and 77 80 5469 5472 O
neck 81 85 5473 5477 B-cancer
lesions 86 93 5478 5485 I-cancer
that 94 98 5486 5490 O
could 99 104 5491 5496 O
compromise 105 115 5497 5507 O
the 116 119 5508 5511 O
airway 120 126 5512 5518 O
or 127 129 5519 5521 O
great 130 135 5522 5527 O
vessels 136 143 5528 5535 O
, 143 144 5535 5536 O
brachial 145 153 5537 5545 B-cancer
or 154 156 5546 5548 O
lumbar 157 163 5549 5555 B-cancer
plexus 164 170 5556 5562 I-cancer
lesions 171 178 5563 5570 I-cancer
that 179 183 5571 5575 O
could 184 189 5576 5581 O
cause 190 195 5582 5587 O
nerve 196 201 5588 5593 O
compression 202 213 5594 5605 O
and 214 217 5606 5609 O
loss 218 222 5610 5614 O
of 223 225 5615 5617 O
function 226 234 5618 5626 O
, 234 235 5626 5627 O
lesions 236 243 5628 5635 O
that 244 248 5636 5640 O
could 249 254 5641 5646 O
result 255 261 5647 5653 O
in 262 264 5654 5656 O
major 265 270 5657 5662 O
deformity 271 280 5663 5672 O
( 281 282 5673 5674 O
e.g. 282 286 5674 5678 O
, 286 287 5678 5679 O
orbital 288 295 5680 5687 B-cancer
lesions 296 303 5688 5695 I-cancer
) 303 304 5695 5696 O
or 305 307 5697 5699 O
significant 308 319 5700 5711 O
cosmetic 320 328 5712 5720 B-chronic_disease
problems 329 337 5721 5729 I-chronic_disease
, 337 338 5729 5730 O
lesions 339 346 5731 5738 O
of 347 349 5739 5741 O
the 350 353 5742 5745 O
extremity 354 363 5746 5755 O
that 364 368 5756 5760 O
cause 369 374 5761 5766 O
limb 375 379 5767 5771 B-chronic_disease
hypertrophy 380 391 5772 5783 I-chronic_disease
or 392 394 5784 5786 O
loss 395 399 5787 5791 O
of 400 402 5792 5794 O
function 403 411 5795 5803 O
, 411 412 5803 5804 O
and 413 416 5805 5808 O
painful 417 424 5809 5816 O
lesions 425 432 5817 5824 O
in 433 435 5825 5827 O
patients 436 444 5828 5836 O
with 445 449 5837 5841 O
NF1 450 453 5842 5845 B-chronic_disease

Platelet 0 8 5846 5854 B-clinical_variable
count 9 14 5855 5860 I-clinical_variable
> 15 16 5861 5862 O
= 16 17 5862 5863 O
100 18 21 5864 5867 B-lower_bound
( 22 23 5868 5869 I-lower_bound
SqrRoot 23 30 5869 5876 I-lower_bound
) 30 31 5876 5877 I-lower_bound
10 32 34 5878 5880 I-lower_bound
^ 34 35 5880 5881 I-lower_bound
9 35 36 5881 5882 I-lower_bound
/ 36 37 5882 5883 I-lower_bound
L 37 38 5883 5884 I-lower_bound

Prior 0 5 5885 5890 O
hepatitis 6 15 5891 5900 B-chronic_disease
infection 16 25 5901 5910 I-chronic_disease
that 26 30 5911 5915 O
has 31 34 5916 5919 O
been 35 39 5920 5924 O
treated 40 47 5925 5932 O
with 48 52 5933 5937 O
highly 53 59 5938 5944 O
effective 60 69 5945 5954 O
therapy 70 77 5955 5962 B-treatment
with 78 82 5963 5967 O
no 83 85 5968 5970 O
evidence 86 94 5971 5979 O
of 95 97 5980 5982 O
residual 98 106 5983 5991 O
infection 107 116 5992 6001 O
and 117 120 6002 6005 O
with 121 125 6006 6010 O
normal 126 132 6011 6017 O
liver 133 138 6018 6023 O
function 139 147 6024 6032 O
( 148 149 6033 6034 O
ALT 149 152 6034 6037 B-clinical_variable
, 152 153 6037 6038 O
AST 154 157 6039 6042 B-clinical_variable
, 157 158 6042 6043 O
total 159 164 6044 6049 B-clinical_variable
and 165 168 6050 6053 O
direct 169 175 6054 6060 B-clinical_variable
bilirubin 176 185 6061 6070 I-clinical_variable
less 186 190 6071 6075 O
than 191 195 6076 6080 O
or 196 198 6081 6083 O
equal 199 204 6084 6089 O
to 205 207 6090 6092 O
ULN 208 211 6093 6096 O
) 211 212 6096 6097 O
is 213 215 6098 6100 O
allowed 216 223 6101 6108 O

Serum 0 5 6109 6114 B-clinical_variable
creatinine 6 16 6115 6125 I-clinical_variable
less 17 21 6126 6130 O
than 22 26 6131 6135 O
or 27 29 6136 6138 O
equal 30 35 6139 6144 O
to 36 38 6145 6147 O
1.5 39 42 6148 6151 B-upper_bound
( 43 44 6152 6153 I-upper_bound
SqrRoot 44 51 6153 6160 I-upper_bound
) 51 52 6160 6161 I-upper_bound
ULN 53 56 6162 6165 I-upper_bound

Six 0 3 6166 6169 B-lower_bound
or 4 6 6170 6172 O
more 7 11 6173 6177 O
cafe 12 16 6178 6182 B-clinical_variable
- 16 17 6182 6183 I-clinical_variable
au 17 19 6183 6185 I-clinical_variable
- 19 20 6185 6186 I-clinical_variable
lait 20 24 6186 6190 I-clinical_variable
macules 25 32 6191 6198 I-clinical_variable
( 33 34 6199 6200 O
greater 34 41 6200 6207 O
than 42 46 6208 6212 O
or 47 49 6213 6215 O
equal 50 55 6216 6221 O
to 56 58 6222 6224 O
0.5 59 62 6225 6228 B-lower_bound
cm 62 64 6228 6230 I-lower_bound
in 65 67 6231 6233 O
prepubertal 68 79 6234 6245 O
subjects 80 88 6246 6254 O
or 89 91 6255 6257 O
greater 92 99 6258 6265 O
than 100 104 6266 6270 O
or 105 107 6271 6273 O
equal 108 113 6274 6279 O
to 114 116 6280 6282 O
1.5 117 120 6283 6286 B-lower_bound
cm 121 123 6287 6289 I-lower_bound
in 124 126 6290 6292 O
post 127 131 6293 6297 O
pubertal 132 140 6298 6306 O
subjects 141 149 6307 6315 O
) 149 150 6315 6316 O

Subjects 0 8 6317 6325 O
who 9 12 6326 6329 O
are 13 16 6330 6333 O
wheelchair 17 27 6334 6344 O
bound 28 33 6345 6350 O
because 34 41 6351 6358 O
of 42 44 6359 6361 O
paralysis 45 54 6362 6371 B-chronic_disease
will 55 59 6372 6376 O
be 60 62 6377 6379 O
considered 63 73 6380 6390 O
ambulatory 74 84 6391 6401 O
when 85 89 6402 6406 O
they 90 94 6407 6411 O
are 95 98 6412 6415 O
up 99 101 6416 6418 O
in 102 104 6419 6421 O
their 105 110 6422 6427 O
wheelchair 111 121 6428 6438 O

Surgery 0 7 6439 6446 B-treatment
: 7 8 6446 6447 O
greater 9 16 6448 6455 O
than 17 21 6456 6460 O
or 22 24 6461 6463 O
equal 25 30 6464 6469 O
to 31 33 6470 6472 O
14 34 36 6473 6475 B-lower_bound
days 37 41 6476 6480 I-lower_bound
from 42 46 6481 6485 O
surgery 47 54 6486 6493 B-treatment

TBil 0 4 6494 6498 B-clinical_variable
and 5 8 6499 6502 O
DBil 9 13 6503 6507 B-clinical_variable
less 14 18 6508 6512 O
than 19 23 6513 6517 O
or 24 26 6518 6520 O
equal 27 32 6521 6526 O
to 33 35 6527 6529 O
ULN 36 39 6530 6533 O
with 40 44 6534 6538 O
an 45 47 6539 6541 O
exception 48 57 6542 6551 O
of 58 60 6552 6554 O
patients 61 69 6555 6563 O
with 70 74 6564 6568 O
confirmed 75 84 6569 6578 O
Gilbert 85 92 6579 6586 B-chronic_disease
's 92 94 6586 6588 I-chronic_disease
syndrome 95 103 6589 6597 I-chronic_disease

There 0 5 6598 6603 O
are 6 9 6604 6607 O
no 10 12 6608 6610 O
limits 13 19 6611 6617 O
on 20 22 6618 6620 O
number 23 29 6621 6627 O
of 30 32 6628 6630 O
prior 33 38 6631 6636 B-treatment
therapeutic 39 50 6637 6648 I-treatment
regimens 51 59 6649 6657 I-treatment

These 0 5 6658 6663 O
may 6 9 6664 6667 O
include 10 17 6668 6675 O
primary 18 25 6676 6683 B-cancer
neoplasms 26 35 6684 6693 I-cancer
of 36 38 6694 6696 O
the 39 42 6697 6700 O
central 43 50 6701 6708 O
nervous 51 58 6709 6716 O
system 59 65 6717 6723 O
, 65 66 6723 6724 O
such 67 71 6725 6729 O
as 72 74 6730 6732 O
high 75 79 6733 6737 O
- 79 80 6737 6738 O
grade 80 85 6738 6743 O
( 86 87 6744 6745 O
WHO 87 90 6745 6748 B-clinical_variable
grade 91 96 6749 6754 I-clinical_variable
III 97 100 6755 6758 B-lower_bound
- 100 101 6758 6759 O
IV 101 103 6759 6761 B-upper_bound
) 103 104 6761 6762 O
glioma 105 111 6763 6769 B-cancer

Two 0 3 6770 6773 O
or 4 6 6774 6776 O
more 7 11 6777 6781 O
Lisch 12 17 6782 6787 B-cancer
nodules 18 25 6788 6795 I-cancer

Uncontrolled 0 12 6796 6808 O
intercurrent 13 25 6809 6821 O
illness 26 33 6822 6829 O
including 34 43 6830 6839 O
, 43 44 6839 6840 O
but 45 48 6841 6844 O
not 49 52 6845 6848 O
limited 53 60 6849 6856 O
to 61 63 6857 6859 O
, 63 64 6859 6860 O
ongoing 65 72 6861 6868 O
or 73 75 6869 6871 O
active 76 82 6872 6878 B-chronic_disease
infection 83 92 6879 6888 I-chronic_disease
, 92 93 6888 6889 O
symptomatic 94 105 6890 6901 O
congestive 106 116 6902 6912 B-chronic_disease
heart 117 122 6913 6918 I-chronic_disease
failure 123 130 6919 6926 I-chronic_disease
, 130 131 6926 6927 O
unstable 132 140 6928 6936 B-chronic_disease
angina 141 147 6937 6943 I-chronic_disease
pectoris 148 156 6944 6952 I-chronic_disease
, 156 157 6952 6953 O
cardiac 158 165 6954 6961 B-chronic_disease
arrhythmia 166 176 6962 6972 I-chronic_disease
, 176 177 6972 6973 O
or 178 180 6974 6976 O
psychiatric 181 192 6977 6988 B-chronic_disease
illness 193 200 6989 6996 I-chronic_disease
/ 200 201 6996 6997 I-chronic_disease
social 201 207 6997 7003 I-chronic_disease
situations 208 218 7004 7014 I-chronic_disease
that 219 223 7015 7019 O
would 224 229 7020 7025 O
limit 230 235 7026 7031 O
compliance 236 246 7032 7042 O
with 247 251 7043 7047 O
study 252 257 7048 7053 O
requirements 258 270 7054 7066 O

XRT 0 3 7067 7070 B-treatment
: 3 4 7070 7071 O
At 5 7 7072 7074 O
least 8 13 7075 7080 O
7 14 15 7081 7082 B-lower_bound
days 16 20 7083 7087 I-lower_bound
after 21 26 7088 7093 I-lower_bound
local 27 32 7094 7099 B-treatment
palliative 33 43 7100 7110 I-treatment
XRT 44 47 7111 7114 I-treatment
( 48 49 7115 7116 O
small 49 54 7116 7121 O
port 55 59 7122 7126 O
) 59 60 7126 7127 O

greater 0 7 7128 7135 O
than 8 12 7136 7140 O
or 13 15 7141 7143 O
equal 16 21 7144 7149 O
to 22 24 7150 7152 O
14 25 27 7153 7155 B-lower_bound
days 28 32 7156 7160 I-lower_bound
from 33 37 7161 7165 O
whole 38 43 7166 7171 B-treatment
brain 44 49 7172 7177 I-treatment
radiation 50 59 7178 7187 I-treatment
, 59 60 7187 7188 O
craniospinal 61 73 7189 7201 B-treatment
radiation 74 83 7202 7211 I-treatment
, 83 84 7211 7212 O
or 85 87 7213 7215 O
targeted 88 96 7216 7224 B-treatment
radiation 97 106 7225 7234 I-treatment
to 107 109 7235 7237 O
CNS 110 113 7238 7241 B-cancer
tumors 114 120 7242 7248 I-cancer

must 0 4 7249 7253 O
be 5 7 7254 7256 O
off 8 11 7257 7260 O
immunosuppressive 12 29 7261 7278 B-treatment
therapy 30 37 7279 7286 I-treatment
for 38 41 7287 7290 O
at 42 44 7291 7293 O
least 45 50 7294 7299 O
4 51 52 7300 7301 B-lower_bound
weeks 53 58 7302 7307 I-lower_bound
and 59 62 7308 7311 O
have 63 67 7312 7316 O
no 68 70 7317 7319 O
active 71 77 7320 7326 B-chronic_disease
graft 78 83 7327 7332 I-chronic_disease
- 83 84 7332 7333 I-chronic_disease
versus 84 90 7333 7339 I-chronic_disease
- 90 91 7339 7340 I-chronic_disease
host 91 95 7340 7344 I-chronic_disease
disease 96 103 7345 7352 I-chronic_disease
( 104 105 7353 7354 I-chronic_disease
GVHD 105 109 7354 7358 I-chronic_disease
) 109 110 7358 7359 I-chronic_disease
at 111 113 7360 7362 O
the 114 117 7363 7366 O
time 118 122 7367 7371 O
of 123 125 7372 7374 O
entry 126 131 7375 7380 O
onto 132 136 7381 7385 O
this 137 141 7386 7390 O
trial 142 147 7391 7396 O

patients 0 8 7397 7405 O
with 9 13 7406 7410 O
NF1 14 17 7411 7414 B-chronic_disease
and 18 21 7415 7418 O
with 22 26 7419 7423 O
malignant 27 36 7424 7433 B-cancer
peripheral 37 47 7434 7444 I-cancer
nerve 48 53 7445 7450 I-cancer
sheath 54 60 7451 7457 I-cancer
tumor 61 66 7458 7463 I-cancer
( 67 68 7464 7465 I-cancer
MPNST 68 73 7465 7470 I-cancer
) 73 74 7470 7471 I-cancer

patients 0 8 7472 7480 O
with 9 13 7481 7485 O
confirmed 14 23 7486 7495 O
Gilberts 24 32 7496 7504 B-chronic_disease
syndrome 33 41 7505 7513 I-chronic_disease
, 41 42 7513 7514 O
the 43 46 7515 7518 O
TBil 47 51 7519 7523 B-clinical_variable
should 52 58 7524 7530 O
be 59 61 7531 7533 O
less 62 66 7534 7538 O
than 67 71 7539 7543 O
or 72 74 7544 7546 O
equal 75 80 7547 7552 O
to 81 83 7553 7555 O
1.5 84 87 7556 7559 B-upper_bound
( 88 89 7560 7561 I-upper_bound
SqrRoot 89 96 7561 7568 I-upper_bound
) 96 97 7568 7569 I-upper_bound
ULN 98 101 7570 7573 I-upper_bound

